Intellectual Property & DMCA Policy

Patient Protect LLC actively defends the proprietary editorial work, breach intelligence compilations, and analytical methodology that make HIPAA Pulse possible. This page describes what is protected, what uses are prohibited, how we enforce our rights, and how rights holders can contact our Designated Agent under the Digital Millennium Copyright Act (17 U.S.C. § 512).

1. Proprietary Assets

The following are proprietary to Patient Protect LLC and are protected by U.S. copyright, trademark, trade dress, and where applicable trade secret law:

HIPAA Pulse editorial content: Aggregator briefs, pattern analyses, regulatory coverage, and any other articles published at hipaapulse.com, including AI-assisted editorial work.
Breach intelligence compilation: The breach intelligence tracker, its data compilation, classification methodology, severity scoring, geographic and entity views, and analytical overlays. Individual data points may originate from public government sources; the aggregation, organization, and analytical treatment constitute original copyrightable work.
Editorial methodology: The HIPAA Pulse voice and editorial standards, the rewriter system prompts, the forbidden-vocabulary rules, the QA lint logic, and the multi-source classification rubric.
Analytical frameworks: Transparency-Adjusted Risk Function (TARF), Dark-Market Value Index (DMVI), AI Amplification Factor (AAF), Healthcare Transparency Index (HTI), and the Cyber-Economic Stack framework. Published through the Secure Care Research Institute (SSRN papers 5257628 and 5792382). Academic citation with attribution is permitted; commercial reuse is not.
Publication design and trade dress: The HIPAA Pulse name, masthead, design system, color palette, typography, and the breach-tracker UI.
Trademarks:HIPAA Pulse™, Patient Protect™, PIPAA™, and Secure Care Research Institute™ are trademarks of Patient Protect LLC.

2. Prohibited Uses

Without prior written authorization from Patient Protect LLC, the following are prohibited:

Reproduction, republication, or redistribution of any proprietary content, in whole or in substantial part.
Automated scraping, crawling, or data harvesting of the publication, the breach tracker, or any tool output, except as a public search engine following our robots.txt protocol.
Use of HIPAA Pulse content, frameworks, scoring outputs, or editorial methodology as training data, fine-tuning data, or evaluation material for machine learning or AI systems. This prohibition is asserted regardless of whether the content is publicly accessible, and applies to all reproductions in datasets, training corpora, and derivative model outputs.
Use of our methodology, editorial work, or breach data compilation for competitive intelligence, benchmarking, or derivative commercial products.
Creation of derivative works based on our frameworks, classification rubric, or analytical systems.
Embedding or framing the publication or its components on third-party sites without an executed embed license.
Removal or alteration of attribution, copyright notices, bylines, or citation markers.

3. Enforcement

We actively monitor for unauthorized use of our proprietary assets, including in AI-generated outputs and competing publications. Violations may result in:

DMCA takedown notices issued to hosting providers, search engines, and AI platforms.
Cease-and-desist action and formal demand letters.
Civil litigation for copyright infringement, trademark infringement, misappropriation, and unfair competition.
Referral to relevant professional, regulatory, or academic integrity bodies where applicable.

4. Reporting Infringement of HIPAA Pulse IP

If you have identified unauthorized reproduction of HIPAA Pulse content, breach data, frameworks, or trade dress — on a competitor site, in another publication, in AI-generated output, or elsewhere — report it through our publisher.

For initial editorial routing, email editor@hipaapulse.com with the infringing URL or source, a description of the asset involved, and any supporting evidence (screenshots, timestamps, prompts that produced the output). For formal DMCA notices, see Section 6 below.

5. DMCA Safe Harbor Notice

Patient Protect respects the intellectual property rights of others. In the limited circumstances where user-submitted content on our services is alleged to infringe a third party’s copyright, we comply with the notice-and-takedown procedures of 17 U.S.C. § 512.

6. Designated Copyright Agent

HIPAA Pulse is published by Patient Protect LLC. The Designated Copyright Agent under 17 U.S.C. § 512 is registered to Patient Protect LLC. The formal designated-agent contact, mailing address, and notice procedure are documented in the Patient Protect Intellectual Property & DMCA Policy:

patient-protect.com/dmca
Designated Agent contact · formal notice procedure · counter-notification process

A valid notice must include:

A signature of the rights holder or authorized agent;
Identification of the copyrighted work;
The URL of the allegedly infringing material;
Your contact information;
A good-faith statement that the use is unauthorized;
A statement under penalty of perjury that the information is accurate and you are authorized to act on behalf of the rights holder.

7. Counter-Notification & Repeat Infringers

Content providers whose material has been removed may submit a counter-notification meeting the requirements of § 512(g) through the formal procedure documented at patient-protect.com/dmca. Patient Protect will terminate access for repeat infringers in appropriate circumstances.